Replies to post #32638 on RespireRx Pharmaceuticals Inc (fka RSPI)

[DewDiligence]

More color on the fenofibrate story: #msg-47808450.

[atheroprevent]

Actually the headlines mislead, it is complicated and depends on the individual and the types of therapy used for diabetes. Aggressive therapy using noninsulin, non SU type therapy early is extremely effective along with life style change in producing very favorable results. You have to see someone vested in cardiovascular disease prevention.

[atheroprevent]

Of further interest, the Accord trial tarnished 2 Novartis drugs while Amln looks to move forward with the once weekly Byetta today. I am sorry you dropped your interest in Amln, Jerry. Byetta is one of the few diabetes drugs with associated with weight loss.